Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets

ABSTRACT: Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets

PROVIDER: PRJNA577107 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10267509.fastq.gz	Fastqsanger.gz
	SRR10267510.fastq.gz	Fastqsanger.gz
	SRR10267511.fastq.gz	Fastqsanger.gz
	SRR10267512.fastq.gz	Fastqsanger.gz
	SRR10267513.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets

Project description:Purpose: Biliary tract cancers (BTCs) carry a very poor prognosis and have no approved targeted therapies. Recent genomic profiling of primary BTCs identified a number of potentially actionable drug targets, however accurate model systems to evaluate these targets are currently lacking. The purpose of this study was to compare the genomic landscape of commonly used BTC cell lines to primary BTCs, and to utilize these models for drug target evaluation. Design: Twenty BTC cell lines were profiled by RNA-seq analysis. Results: Transcriptomic profiling of BTC cell lines identified two subtypes, enriched for epithelial and mesenchymal genes respectively, which were also identified in primary BTC. Conclusions: Cell lines harbor similar genomic alterations to primary BTCs. Integration of cell line and primary cancer data identify novel molecular subsets, and highlight specific molecular vulnerabilities in BTC.

2019-10-12 | GSE138772 | GEO

Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets.

Project description:Biliary tract cancers (BTCs) currently have no approved targeted therapies. Although genomic profiling of primary BTCs has identified multiple potential drug targets, accurate models are needed for their evaluation. Genomic profiling of 22 BTC cell lines revealed they harbor similar mutational signatures, recurrently mutated genes, and genomic alterations to primary tumors. Transcriptomic profiling identified two major subtypes, enriched for epithelial and mesenchymal genes, which were also evident in patient-derived organoids and primary tumors. Interrogating these models revealed multiple mechanisms of MAPK signaling activation in BTC, including co-occurrence of low-activity BRAF and MEK mutations with receptor tyrosine kinase overexpression. Finally, BTC cell lines with altered ERBB2 or FGFRs were exquisitely sensitive to specific targeted agents, whereas surprisingly, IDH1-mutant lines did not respond to IDH1 inhibitors in vitro. These findings establish BTC cell lines as robust models of primary disease, reveal specific molecular disease subsets, and highlight specific molecular vulnerabilities in these cancers.

| S-EPMC6889747 | biostudies-literature

Sphere cultured biliary tract cancer cell lines SNU245 and SNU1196

Project description:We analyzed sphere cultured biliary tract cancer cell lines and analysed cancer stem cells asociated-differentially expressed genes by microarray analysis. biliary tract cancer stem cells(CSCs) associated DEG

2024-03-27 | GSE233893 | GEO

MicroRNA markers for the diagnosis of pancreatic and biliary tract cancers

Project description:MicroRNAs from serum samples could detect pancreatic and biliary tract cancer patients more accurately than other traditional markers. Prospective miRNA markers for pancreatic/biliary tract cancer were selected in the training cohort. Using these miRNAs, discriminant analysis was performed, and the diagnostic accuracy, sensitivity and specificity were calculated in the test cohort.

2015-03-01 | E-GEOD-59856 | biostudies-arrayexpress

Project description:Tumour and adjacent components from human resected biliary tract cancers were characterised for the expression of immunorelated transcripts

2018-02-14 | GSE90698 | GEO

Project description:Adjacent components from human resected biliary tract cancers were characterised for the expression of immunorelated transcripts

2018-02-14 | GSE90699 | GEO

MicroRNA markers for the diagnosis of pancreatic and biliary tract cancers

Project description:MicroRNAs from serum samples could detect pancreatic and biliary tract cancer patients more accurately than other traditional markers.

2015-03-01 | GSE59856 | GEO

Comparative gene expression analysis of biliary tract cancer cells under organoid culture and adherent culture.

Project description:Organoid culture is important for maintenance of epithelial cell characteristics, stemness, and tumorigenic activity of biliary tract cancer initiating cells. To investigate whether organoid culture maintain cancer stem cell properties of biliary tract cancer initiating cells, we compared the gene expression changes between organoid culture and adherent culture.

2021-05-19 | GSE151442 | GEO

Gene expression profiles in organoids derived from biliary tract carcinomas [MAA-17164_3]

Project description:In the present study, we established organoids using cancer and non-cancer tissues obtained from patients with biliary tract carcinomas and investigated compehensive gene expression profiles.

2019-03-15 | GSE112407 | GEO

microRNA expression profiles in organoids derived from biliary tract carcinomas [MAA-17164_2]

2019-03-15 | GSE112406 | GEO